Fashionable, but What is Their Real Clinical Usefulness? NLR, LMR, and PLR as a Promising Indicator in Colorectal Cancer Prognosis: A Systematic Review

References

• Son W, Shin SJ, Park SH, et al. Clinical impact of combined modified glasgow prognostic score and c-reactive protein/albumin ratio in patients with colorectal cancer. Diagnostics. 2020;10(11):859. doi:10.3390/DIAGNOSTICS10110859
   Web of Science ®Google Scholar
• Ying HQ, Deng QW, He BS, et al. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients. Med Oncol. 2014;31(12):1–8. doi:10.1007/S12032-014-0305-0
   Web of Science ®Google Scholar
• Wojciechowska U, Didkowska J. Nowotwory Złośliwe w Polsce w 2018 [Malignant tumors in Poland in 2018]. Krajowy Rejestr Nowotworów; 2020.
   Google Scholar
• Praktyce OW, Zyśk R, Wysocki P, Wyrwicz L. Colorectal cancer — the social significance of changes in the epidemiology and treatment options in Poland. Oncol Clin Pract. 2014;10(4):212–223.
   Google Scholar
• Korniluk A, Koper O, Kemona H, Dymicka-Piekarska V. From inflammation to cancer. Ir J Med Sci. 2017;186(1):57–62. doi:10.1007/S11845-016-1464-0
   Web of Science ®Google Scholar
• Dymicka-Piekarska V, Koper-Lenkiewicz OM, Zińczuk J, Kratz E, Kamińska J. Inflammatory cell-associated tumors. Not only macrophages (TAMs), fibroblasts (TAFs) and neutrophils (TANs) can infiltrate the tumor microenvironment. The unique role of tumor associated platelets (TAPs). Cancer Immunol Immunother. 2021;70(6):1497–1510. doi:10.1007/S00262-020-02758-7
   Web of Science ®Google Scholar
• Balkwill FR, Mantovani A. Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol. 2012;22(1):33–40. doi:10.1016/J.SEMCANCER.2011.12.005
   PubMed Web of Science ®Google Scholar
• Okayasu I, Ohkusa T, Kajiura K, Kanno J, Sakamoto S. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut. 1996;39(1):87–92. doi:10.1136/GUT.39.1.87
   Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–867. doi:10.1038/NATURE01322
   PubMed Web of Science ®Google Scholar
• Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27(45):5904–5912. doi:10.1038/ONC.2008.271
   PubMed Web of Science ®Google Scholar
• Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007;117(5):1175–1183. doi:10.1172/JCI31537
   PubMed Web of Science ®Google Scholar
• de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6(1):24–37. doi:10.1038/NRC1782
   PubMed Web of Science ®Google Scholar
• Kasprzak A. The role of tumor microenvironment cells in colorectal cancer (CRC) cachexia. Int J Mol Sci. 2021;22(4):1–34. doi:10.3390/IJMS22041565
   Web of Science ®Google Scholar
• Piskor BM, Pryczynicz A, Lubowicka E, et al. Immunohistochemical expression of Fascin-1 in colorectal cancer in relation to clinical and pathological parameters. Folia Histochem Cytobiol. 2018;56:106–112. doi:10.5603/FHC.a2018.0011
   Web of Science ®Google Scholar
• Zińczuk J, Maciejczyk M, Zaręba K, et al. Pro-oxidant enzymes, redox balance and oxidative damage to proteins, lipids and DNA in colorectal cancer tissue. is oxidative stress dependent on tumour budding and inflammatory infiltration? Cancers. 2020;12:1636. doi:10.3390/cancers12061636
   Web of Science ®Google Scholar
• Zińczuk J, Zaręba K, Kamińska J, et al. Association of tumour microenvironment with protein glycooxidation, DNA damage, and nitrosative stress in colorectal cancer. Cancer Manag Res. 2021;13:6329–6348. doi:10.2147/CMAR.S314940
   PubMedGoogle Scholar
• Dorf J, Zaręba K, Matowicka-Karna J, et al. May the nitrosative and carbonyl stress promote inflammation in patients with colorectal cancer? J Inflamm Res. 2022;15:4585–4600. doi:10.2147/JIR.S374387
   PubMed Web of Science ®Google Scholar
• Zhang Q, Song MM, Zhang X, et al. Association of systemic inflammation with survival in patients with cancer cachexia: results from a multicentre cohort study. J Cachexia Sarcopenia Muscle. 2021;12(6):1466–1476. doi:10.1002/JCSM.12761
   PubMed Web of Science ®Google Scholar
• Zhang L, Wei Z, Xu A, Zang JH. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study. Int J Surg. 2018;56:320–327. doi:10.1016/J.IJSU.2018.06.037
   Web of Science ®Google Scholar
• Mercan R, Bitik B, Tufan A, et al. The association between neutrophil/lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis. J Clin Lab Anal. 2016;30(5):597–601. doi:10.1002/JCLA.21908
   PubMed Web of Science ®Google Scholar
• Koiwa M, Goto S, Takahashi K, Kamada T, Takai S, Nakamura H. Neutrophil/lymphocyte ratio in patients with rheumatoid arthritis treated with biological agents. J Nippon Med Sch. 2016;83(3):118–124. doi:10.1272/JNMS.83.118
   PubMed Web of Science ®Google Scholar
• Wang X, Qiu L, Li Z, Wang XY, Yi H. Understanding the multifaceted role of neutrophils in cancer and autoimmune diseases. Front Immunol. 2018;9. doi:10.3389/FIMMU.2018.02456
   Web of Science ®Google Scholar
• Angkananard T, Anothaisintawee T, McEvoy M, Attia J, Thakkinstian A. Neutrophil lymphocyte ratio and cardiovascular disease risk: a systematic review and meta-analysis. Biomed Res Int. 2018;2018:1–11. doi:10.1155/2018/2703518
   Web of Science ®Google Scholar
• Mertoglu C, Gunay M. Neutrophil-Lymphocyte ratio and Platelet-Lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus. Diabetes Metab Syndr. 2017;11(Suppl 1):S127–S131. doi:10.1016/J.DSX.2016.12.021
   PubMedGoogle Scholar
• Yang AP, Liu J, Tao W, Li H. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020;84:106504. doi:10.1016/J.INTIMP.2020.106504
   PubMed Web of Science ®Google Scholar
• Xiao Q, Zhang B, Deng X, et al. The preoperative neutrophil-to-lymphocyte ratio is a novel immune parameter for the prognosis of esophageal basaloid squamous cell carcinoma. PLoS One. 2016;11(12):e0168299. doi:10.1371/JOURNAL.PONE.0168299
   PubMed Web of Science ®Google Scholar
• Winther-Larsen A, Aggerholm-Pedersen N, Sandfeld-Paulsen B. Inflammation scores as prognostic biomarkers in small cell lung cancer: a systematic review and meta-analysis. Syst Rev. 2021;10(1). doi:10.1186/S13643-021-01585-W
   Web of Science ®Google Scholar
• Kim DY, Kim IS, Park SG, Kim H, Choi YJ, Seol YM. Prognostic value of posttreatment neutrophil-lymphocyte ratio in head and neck squamous cell carcinoma treated by chemoradiotherapy. Auris Nasus Larynx. 2017;44(2):199–204. doi:10.1016/J.ANL.2016.05.013
   Web of Science ®Google Scholar
• Azab B, Bhatt VR, Phookan J, et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol. 2012;19(1):217–224. doi:10.1245/S10434-011-1814-0
   PubMed Web of Science ®Google Scholar
• Hayama T, Ozawa T, Tsukamoto M, et al. Predicting overall survival using preoperative nutritional and inflammation status for colorectal cancer. In Vivo. 2022;36(1):450–457. doi:10.21873/INVIVO.12724
   Web of Science ®Google Scholar
• Li X, Guo D, Chu L, et al. Potential diagnostic value of combining inflammatory cell ratios with carcinoembryonic antigen for colorectal cancer. Cancer Manag Res. 2019;11:9631–9640. doi:10.2147/CMAR.S222756
   PubMed Web of Science ®Google Scholar
• Tan D, Fu Y, Tong W, Li F. Prognostic significance of lymphocyte to monocyte ratio in colorectal cancer: a meta-analysis. Int J Surg. 2018;55:128–138. doi:10.1016/J.IJSU.2018.05.030
   Web of Science ®Google Scholar
• Kostakis ID, Vaiopoulos AG, Garoufalia Z, et al. What can preoperative blood tests tell us about colorectal cancer? JBUON. 2018;23(1):84–95.
   Google Scholar
• Sánchez JCS, Quiñones JLG, Muñoz-Velandia OM, Zambrano MA, Ramírez JRT. High mean platelet volume and neutrophil-to-lymphocyte ratio are predictors of mortality in patients with HIV-related non-Hodgkin’s lymphoma. Acta Haematol Pol. 2021;52(3):195–201. doi:10.5603/AHP.2021.0037
   Google Scholar
• Heeke S, Mograbi B, Alix-Panabières C, Hofman P. Never travel alone: the crosstalk of circulating tumor cells and the blood microenvironment. Cells. 2019;8(7):714. doi:10.3390/CELLS8070714
   Web of Science ®Google Scholar
• Herold Z, Herold M, Lohinszky J, Szasz AM, Dank M, Somogyi A. Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer. World J Clin Cases. 2022;10(20):6825–6844. doi:10.12998/wjcc.v10.i20.6825
   Web of Science ®Google Scholar
• Yamamoto T, Kawada K, Obama K. Inflammation-related biomarkers for the prediction of prognosis in colorectal cancer patients. Int J Mol Sci. 2021;22(15):8002. doi:10.3390/IJMS22158002
   PubMed Web of Science ®Google Scholar
• Forget P, Khalifa C, Defour JP, Latinne D, van Pel MC, de Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2017;10(1):1–4. doi:10.1186/S13104-016-2335-5
   PubMedGoogle Scholar
• Kim JH, Lee JY, Kim HK, et al. Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer. World J Gastroenterol. 2017;23(3):505–515. doi:10.3748/wjg.v23.i3.505
   PubMed Web of Science ®Google Scholar
• He S, Lamers GEM, Beenakker JWM, et al. Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model. J Pathol. 2012;227(4):431–445. doi:10.1002/PATH.4013
   PubMed Web of Science ®Google Scholar
• Klajman A, Cohen R, Bruderman I, Steiner Z, Klajman A. Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. Cancer Res. 1987;47(1):173–177.
   Web of Science ®Google Scholar
• Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature. 2001;411(6835):380–384. doi:10.1038/35077246
   PubMed Web of Science ®Google Scholar
• Yang J, Guo X, Wang M, Ma X, Ye X, Lin P. Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS. Sci Rep. 2017;7(1). doi:10.1038/S41598-017-17130-6
   Google Scholar
• Dou X, Wang R, Yan HJ, et al. Circulating lymphocytes as predictors of sensitivity to preoperative chemoradiotherapy in rectal cancer cases. Asian Pac J Cancer Prev. 2013;14(6):3881–3885. doi:10.7314/APJCP.2013.14.6.3881
   PubMedGoogle Scholar
• Kitayama J, Yasuda K, Kawai K, Sunami E, Nagawa H. Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer. Radiat Oncol. 2010;5(1). doi:10.1186/1748-717X-5-47
   Google Scholar
• Noh OK, Oh SY, Kim YB, Suh KW. Prognostic significance of lymphocyte counts in colon cancer patients treated with FOLFOX chemotherapy. World J Surg. 2017;41(11):2898–2905. doi:10.1007/S00268-017-4104-6
   Web of Science ®Google Scholar
• Li Y, Wu H, Xing C, et al. Prognostic evaluation of colorectal cancer using three new comprehensive indexes related to infection, anemia and coagulation derived from peripheral blood. J Cancer. 2020;11(13):3834–3845. doi:10.7150/jca.42409
   PubMed Web of Science ®Google Scholar
• Chan JCY, Diakos CI, Chan DLH, et al. A longitudinal investigation of inflammatory markers in colorectal cancer patients perioperatively demonstrates benefit in serial remeasurement. Ann Surg. 2018;267(6):1119–1125. doi:10.1097/SLA.0000000000002251
   PubMed Web of Science ®Google Scholar
• Li Y, Jia H, Yu W, et al. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection. Int J Cancer. 2016;139(1):220–231. doi:10.1002/IJC.30071
   Web of Science ®Google Scholar
• Jiang H, Li H, Li A, et al. Preoperative combined hemoglobin, albumin, lymphocyte and platelet levels predict survival in patients with locally advanced colorectal cancer. Oncotarget. 2016;7(44):72076. doi:10.18632/ONCOTARGET.12271
   Google Scholar
• Choi WJ, Cleghorn MC, Jiang H, Jackson TD, Okrainec A, Quereshy FA. Preoperative neutrophil-to-lymphocyte ratio is a better prognostic serum biomarker than platelet-to-lymphocyte ratio in patients undergoing resection for nonmetastatic colorectal cancer. Ann Surg Oncol. 2015;22(Suppl 3):603–613. doi:10.1245/S10434-015-4571-7
   Google Scholar
• Zhan L, Liu Y, Cheng Y, Guo W, Yang J. Predictive value of neutrophil/lymphocyte ratio (NLR) on cardiovascular events in patients with COVID-19. Int J Gen Med. 2021;14:3899–3907. doi:10.2147/IJGM.S317380
   Web of Science ®Google Scholar
• Ming-Sheng F, Mei-Ling D, Xun-Quan C, Yuan-Xin H, Wei-Jie Z, Qin-Cong P. Preoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and CEA as the potential prognostic biomarkers for colorectal cancer. Can J Gastroenterol Hepatol. 2022;2022:1–9. doi:10.1155/2022/3109165
   Web of Science ®Google Scholar
• Ciocan A, Ciocan RA, Al Hajjar N, Gherman CD, Bolboacă SD. Abilities of pre-treatment inflammation ratios as classification or prediction models for patients with colorectal cancer. Diagnostics. 2021;11(3):566. doi:10.3390/DIAGNOSTICS11030566
   Web of Science ®Google Scholar
• Turhan VB, Ünsal A, Gök HF, et al. Predictive value of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratio in determining the stage of colon tumors. Cureus. 2021. doi:10.7759/cureus.18381
   Web of Science ®Google Scholar
• Chen W, Yi HJ, Chen XQ, et al. Prognostic value of the NLR combined with CIP2A in the serum of patients with colorectal cancer. BMC Surg. 2021;21(1). doi:10.1186/s12893-021-01273-5
   Web of Science ®Google Scholar
• Jia W, Yuan L, Ni H, Xu B, Zhao P. Prognostic value of platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, and lymphocyte-to-white blood cell ratio in colorectal cancer patients who received neoadjuvant chemotherapy. Technol Cancer Res Treat. 2021;20:153303382110342. doi:10.1177/15330338211034291
   Web of Science ®Google Scholar
• Xia LJ, Li W, Zhai JC, Yan CW, Chen JB, Yang H. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1-2 rectal cancer. BMC Cancer. 2020;20(1). doi:10.1186/s12885-020-6698-6
   Web of Science ®Google Scholar
• Zou ZY, Liu HL, Ning N, Li SY, Du XH, Li R. Clinical significance of pre-operative neutrophil lymphocyte ratio and platelet lymphocyte ratio as prognostic factors for patients with colorectal cancer. Oncol Lett. 2016;11(3):2241–2248. doi:10.3892/OL.2016.4216
   Web of Science ®Google Scholar
• Okamura Y, Sugiura T, Ito T, et al. Neutrophil to lymphocyte ratio as an indicator of the malignant behaviour of hepatocellular carcinoma. Br J Surg. 2016;103(7):891–898. doi:10.1002/BJS.10123
   Web of Science ®Google Scholar
• Liu Y, Wang ZX, Cao Y, Zhang G, Chen WB, Jiang CP. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy. Hepatobiliary Pancreat Dis Int. 2016;15(3):266–274. doi:10.1016/S1499-3872(16)60094-2
   PubMed Web of Science ®Google Scholar
• Lu SD, Wang YY, Peng NF, et al. Preoperative ratio of neutrophils to lymphocytes predicts postresection survival in selected patients with early or intermediate stage hepatocellular carcinoma. Medicine. 2016;95(5). doi:10.1097/MD.0000000000002722
   Web of Science ®Google Scholar
• Olingy CE, Dinh HQ, Hedrick CC. Monocyte heterogeneity and functions in cancer. J Leukoc Biol. 2019;106(2):309–322. doi:10.1002/JLB.4RI0818-311R
   PubMed Web of Science ®Google Scholar
• Sica A, Allavena P, Mantovani A. Cancer related inflammation: the macrophage connection. Cancer Lett. 2008;267(2):204–215. doi:10.1016/J.CANLET.2008.03.028
   PubMed Web of Science ®Google Scholar
• Rumba R, Cipkina S, Cukure F, Vanags A. Systemic and local inflammation in colorectal cancer. Acta Med Litu. 2018;25(4):185–196. doi:10.6001/ACTAMEDICA.V25I4.3929
   Google Scholar
• Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell. 2006;124(2):263–266. doi:10.1016/J.CELL.2006.01.007
   PubMed Web of Science ®Google Scholar
• Chanmee T, Ontong P, Konno K, Itano N. Tumor-associated macrophages as major players in the tumor microenvironment. Cancers. 2014;6(3):1670–1690. doi:10.3390/CANCERS6031670
   PubMed Web of Science ®Google Scholar
• Singh N, Baby D, Rajguru J, Patil P, Thakkannavar S, Pujari V. Inflammation and cancer. Ann Afr Med. 2019;18(3):121. doi:10.4103/AAM.AAM_56_18
   PubMed Web of Science ®Google Scholar
• Dwyer AR, Greenland EL, Pixley FJ. Promotion of tumor invasion by tumor-associated macrophages: the role of CSF-1-activated phosphatidylinositol 3 kinase and src family kinase motility signaling. Cancers. 2017;9(6):68. doi:10.3390/CANCERS9060068
   Web of Science ®Google Scholar
• Wu Q, Hu T, Zheng E, Deng X, Wang Z. Prognostic role of the lymphocyte-to-monocyte ratio in colorectal cancer: an up-to-date meta-analysis. Medicine. 2017;96(22). doi:10.1097/MD.0000000000007051
   Web of Science ®Google Scholar
• Zhang Y, Liu X, Xu M, Chen K, Li S, Guan G. Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy. Sci Rep. 2020;10(1). doi:10.1038/S41598-020-64684-Z
   Web of Science ®Google Scholar
• Chan JCY, Chan DL, Diakos CI, et al. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg. 2017;265(3):539–546. doi:10.1097/SLA.0000000000001743
   PubMed Web of Science ®Google Scholar
• Basile D, Garattini SK, Corvaja C, et al. The MIMIC study: prognostic role and cutoff definition of monocyte-to-lymphocyte ratio and lactate dehydrogenase levels in metastatic colorectal cancer. Oncologist. 2020;25(8):661–668. doi:10.1634/THEONCOLOGIST.2019-0780
   Web of Science ®Google Scholar
• Shibutani M, Maeda K, Nagahara H, Iseki Y, Ikeya T, Hirakawa K. Prognostic significance of the preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer. Oncol Lett. 2017;13(2):1000–1006. doi:10.3892/OL.2016.5487
   Web of Science ®Google Scholar
• Wagner DD. New links between inflammation and thrombosis. Arterioscler Thromb Vasc Biol. 2005;25(7):1321–1324. doi:10.1161/01.ATV.0000166521.90532.44
   PubMed Web of Science ®Google Scholar
• Stone RL, Nick AM, McNeish IA, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012;366(7):610–618. doi:10.1056/NEJMOA1110352
   PubMed Web of Science ®Google Scholar
• Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K. Preoperative thrombocytosis is associated with survival after surgery for colorectal cancer. J Surg Oncol. 2012;106(7):887–891. doi:10.1002/JSO.23163
   PubMed Web of Science ®Google Scholar
• Rao XD, Zhang H, Xu ZS, Cheng H, Shen W, Wang XP. Poor prognostic role of the pretreatment platelet counts in colorectal cancer: a meta-analysis. Medicine. 2018;97(23):e10831. doi:10.1097/MD.0000000000010831
   PubMed Web of Science ®Google Scholar
• Lin RJ, Afshar-Kharghan V, Schafer AI. Paraneoplastic thrombocytosis: the secrets of tumor self-promotion. Blood. 2014;124(2):184–187. doi:10.1182/blood-2014-03-562538
   PubMed Web of Science ®Google Scholar
• Herczeg G, Somogyi A, Herold M, et al. Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer? Open Med. 2022;17(1):160–173. doi:10.1515/med-2021-0407
   Web of Science ®Google Scholar
• Wojtukiewicz MZ, Sierko E, Hempel D, Tucker SC, Honn KV. Platelets and cancer angiogenesis nexus. Cancer Metastasis Rev. 2017;36(2):249–262. doi:10.1007/S10555-017-9673-1
   PubMed Web of Science ®Google Scholar
• Flad HD, Brandt E. Platelet-derived chemokines: pathophysiology and therapeutic aspects. Cell Mol Life Sci. 2010;67(14):2363–2386. doi:10.1007/S00018-010-0306-X
   Web of Science ®Google Scholar
• Sharma D, Brummel-Ziedins KE, Bouchard BA, Holmes CE. Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer. J Cell Physiol. 2014;229(8):1005–1015. doi:10.1002/JCP.24539
   PubMed Web of Science ®Google Scholar
• Zhao Z, Zhao X, Lu J, Xue J, Liu P, Mao H. Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: a meta-analysis of retrospective studies. Arch Gynecol Obstet. 2018;297(4):849–857. doi:10.1007/S00404-018-4678-8
   PubMed Web of Science ®Google Scholar
• Krenn-Pilko S, Langsenlehner U, Thurner EM, et al. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer. 2014;110(10):2524–2530. doi:10.1038/BJC.2014.163
   PubMed Web of Science ®Google Scholar
• Ding N, Pang Z, Shen H, Ni Y, Du J, Liu Q. The prognostic value of PLR in lung cancer, a meta-analysis based on results from a large consecutive cohort. Sci Rep. 2016;6. doi:10.1038/SREP34823
   Web of Science ®Google Scholar
• Acikgoz O, Cakan B, Demir T, et al. Platelet to lymphocyte ratio is associated with tumor localization and outcomes in metastatic colorectal cancer. Medicine. 2021;100(44):e27712. doi:10.1097/MD.0000000000027712
   PubMed Web of Science ®Google Scholar
• Mo C, Hu Z, Qin S, et al. Diagnostic value of platelet-lymphocyte ratio and hemoglobin-platelet ratio in patients with rectal cancer. J Clin Lab Anal. 2020;34(4). doi:10.1002/jcla.23153
   Web of Science ®Google Scholar
• Pedrazzani C, Mantovani G, Fernandes E, et al. Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer. Sci Rep. 2017;7(1). doi:10.1038/S41598-017-01652-0
   Google Scholar
• Wu Y, Jiang M, Qin Y, Lin F, Lai M. Single and combined use of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and carcinoembryonic antigen in diagnosing gastric cancer. Clin Chim Acta. 2018;481:20–24. doi:10.1016/J.CCA.2018.02.027
   Web of Science ®Google Scholar
• Liu XF, Zhou LY, Wei ZH, et al. The diagnostic role of circulating inflammation-based biomarker in gallbladder carcinoma. Biomark Med. 2018;12(10):1095–1103. doi:10.2217/BMM-2018-0049
   Web of Science ®Google Scholar
• Peng HX, Yang L, He BS, et al. Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC. J Clin Lab Anal. 2017;31(5):e22075. doi:10.1002/JCLA.22075
   Web of Science ®Google Scholar